Malawi’s Parliament investigates theft of falsified medicines
By the AFREEQUE newsroom, based on Malawi24
Malawi’s Parliamentary Committee on Health is investigating the theft of medicines and the circulation of falsified or substandard products. Pharmaceutical companies and the tax authority are due to give evidence until 16 October 2026 to assess the risks to patients, Malawi24 reports.
Malawi’s Parliamentary Committee on Health opened an inquiry on 12 October 2026 into the theft of medicines, the circulation of falsified or substandard products and the safety of treatments sold in the country, Malawi24 reports.
The hearings are due to continue until 16 October and will involve pharmaceutical companies as well as the Malawi Revenue Authority, the country’s tax and customs administration. Victoria Pharmaceuticals Industry Limited and Crown Pharmaceuticals are among the companies listed in the hearing schedule, according to the timetable published by the Malawian Parliament.
The rest of this article is for subscribers.
Try AFREEQUE!
- Every article in full: all the news from Africa, summarised and easy to read
- A local source in 52 of the continent’s 54 countries
- 100% independent: no advertising, no shareholders
- The satisfaction of supporting an independent African news outlet that serves its readers
Discovery offer
€1
for 15 days
then €9.99/month
Try it for €1No commitment · cancel in one click
New subscribers only
🔒 Secure payment with:
Already a subscriber? Log in
Summary produced with the help of artificial intelligence tools, under AFREEQUE’s editorial responsibility.
